Mental Health

Ensysce Biosciences’ Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a...

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder

Amwell Receives Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms

Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve...

Odyssey Behavioral Healthcare Marks 10 Years with Measurable Clinical Outcomes Across Mental Health, Substance Use and Eating Disorder Programs

A decade of outcomes data shows sustained reductions in symptom severity, benchmarked against national averages FRANKLIN, TN / ACCESS Newswire...

Rhelion Life Sciences Confirms Further Delivery of Filament Health’s PEX010 to Germany’s First Psilocybin Compassionate Use Program

Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting...

Black Health & Social Services Hub to Celebrate Grand Opening with Community Health, Culture and Wellness Celebration in Brampton

Brampton, Ontario--(Newsfile Corp. - August 27, 2026) - The Black Health and Social Services (BHSS) Hub Peel will officially celebrate...

Black Book Releases 2026 Behavioral Health EHR and Practice Management Platform Rankings for Independent Ambulatory Physician Practices

Black Book study respondents rate NextGen® Behavioral Health Suite No. 1 overall across mid- and large-size clinician groups, as integrated...

error: Content is protected !!